Here’s a roundup of some of Wednesday’s major pharmaceutical news: An FDA panel gave Human Genome Sciences a boost with a thumbs-up for its lupus drug, Benlysta; Merck’s experimental heart drug appears to work well without side…
When all is said and done, General Motors could easily vault to the top of the list, surpassing Visa’s IPO as the biggest U.S. company offering, and beyond Agriculture Bank of China as the biggest ever in the world. Here’s a lo…
Swiss pharmaceutical giant Roche (RHHBY) said Wednesday it is slashing 6% of its workforce, or 4,800 jobs, most of them in the U.S. This is part of the drugmaker’s plan to get a handle on costs, which comes in response to recent drug setbacks and as th…
Target reported Wednesday morning that net earnings grew 22.6% in the third quarter, beating estimates, as sales rose 3% and the company got a boost from its credit card business. The company also expects fourth quarter compara…
General Motors will increase the size of its IPO by almost one-third to meet strong investor demand.
The company said it will increase the IPO to 478 million common shares, 31% more than the planned 365 million. These figures exclude the amount of sha…